Max, CHOC patient with acute lymphoblastic leukemia (ALL), participates in cancer research trials to improve outcomes and treatments.
Physicians at CHOC lead a new study to improve survival rates of children with pediatric acute lymphoblastic leukemia (ALL).
A CHOC AYA oncology patient uses her experience to give back to others by participating in ongoing cancer research and clinical trials.
Research projects of the winners – 12 of 23 were awarded funding – range from virtual reality training to the use of AI to predict COVID-19.
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.
Attendees of the 2018 Society of Young Adult Oncology/CHOC Leukemia Symposium shared the latest advances in acute leukemia treatment.